Where does Immunis's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Immunis's 2 recorded funding rounds.

Premier Alternatives

Immunis

Irvine, CA · Founded 2019 · Privately Held (backing)

Developer of stem cell-derived therapy designed to treat age and disease-related immune decline. Immunis is based in Irvine, CA and was founded in 2019. Its last known valuation is $75 million. It has raised $37 million across 2 recorded rounds; the latest was a $12 million early-stage round in May 2026.

Last price · $/share

—

Implied valuation

$75.0M

Total raised

$37.0M

Last round

Early Stage VC

May 2026

Cap table — not yet on record

Immunis's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Immunis with a free account

·The complete investor list: 12 names
·Watch Immunis: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Immunis

Where does Immunis's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Immunis's 2 recorded funding rounds.